Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE) - Hémodynamique, Interaction Fibrose et Invasivité Tumorales Hépatiques Accéder directement au contenu
Article Dans Une Revue Neuroendocrinology Année : 2017

Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE)

Éric Baudin
  • Fonction : Auteur
  • PersonId : 957572
Sophie Dominguez
  • Fonction : Auteur
Rosine Guimbaud
  • Fonction : Auteur
  • PersonId : 955028
Thomas R. Walter

Dates et versions

hal-02451453 , version 1 (23-01-2020)

Identifiants

Citer

Guillaume Roquin, Éric Baudin, Catherine Lombard-Bohas, Guillaume Cadiot, Sophie Dominguez, et al.. Chemotherapy for Well-Differentiated Pancreatic Neuroendocrine Tumours with a Ki-67 Index ≥10%: Is There a More Effective Antitumour Regimen? A Retrospective Multicentre Study of the French Group of Endocrine Tumours (GTE). Neuroendocrinology, 2017, 106 (1), pp.38-46. ⟨10.1159/000457955⟩. ⟨hal-02451453⟩
78 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More